Interrelationship among insulin, glucagon and somatostatin secretory responses to exendin-4 in the perfused rat pancreas (Q44462695)

3 December 2017

Interrelationship among insulin, glucagon and somatostatin secretory responses to exendin-4 in the perfused rat pancreas (English)

1 reference

3 December 2017

0 references

1 reference

Ramona A Silvestre

1

1 reference

3 December 2017

Jovita Rodríguez-Gallardo

series ordinal

2

1 reference

3 December 2017

Eva M Egido

series ordinal

3

1 reference

3 December 2017

J Marco

series ordinal

4

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

European Journal of Pharmacology

3 December 2017

1 reference

3 December 2017

469

1 reference

3 December 2017

1-3

1 reference

3 December 2017

195-200

1 reference

Tissue-specific expression of unique mRNAs that encode proglucagon-derived peptides or exendin 4 in the lizard.

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

The entero-insular axis in type 2 diabetes--incretins as therapeutic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

Rat gastric somatostatin and gastrin release: interactions of exendin-4 and truncated glucagon-like peptide-1 (GLP-1) amide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

Measurements of somatostatin-like immunoreactivity in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

Coated Charcoal Immunoassay of Insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

Adaptations of alpha2- and beta-cells of rat and mouse pancreatic islets to starvation, to refeeding after starvation, and to obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

Interplay of nutrients and hormones in the regulation of glucagon release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

Immunoassay of endogenous plasma insulin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901692-3

10.1016/S0014-2999(03)01692-3

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference